JP MORGAN/CALL/VERTEX PHARMACEUTICALS/370/0.1/21.06.24 Share Price

Warrant

DE000JL06S59

Market Closed - Börse Stuttgart 07:40:10 14/06/2024 BST
10.2 EUR +3.87% Intraday chart for JP MORGAN/CALL/VERTEX PHARMACEUTICALS/370/0.1/21.06.24
Current month+48.47%
1 month+74.66%
Date Price Change
14/06/24 10.2 +3.87%
13/06/24 9.82 -7.53%
12/06/24 10.62 +0.28%
11/06/24 10.59 +0.09%
10/06/24 10.58 -1.21%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 07:40 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying VERTEX PHARMACEUTICALS INCORPORATED
Issuer J.P. Morgan
WKN JL06S5
ISINDE000JL06S59
Date issued 28/03/2023
Strike 370 $
Maturity 21/06/2024 (6 Days)
Parity 10 : 1
Emission price 2.73
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 10.71
Lowest since issue 2.54
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.299
Difference Strike -110.7 $
Difference Strike %-29.93%
Intrinsic value 10.34

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
More about the company

Ratings for Vertex Pharmaceuticals Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Vertex Pharmaceuticals Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
480.7 USD
Average target price
463.4 USD
Spread / Average Target
-3.60%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW